PLUS THERAPEUTICS, INC. — Director's Dealing 2016

Aug 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-08-10

Reporting Person: HARRIS JOHN DAVID (VP and GM Cell Therapy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-10	Common Stock	P	2500	$2.03	Acquired	7000	Direct